nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—Sensation of foreign body—Cyclosporine—focal segmental glomerulosclerosis	0.0455	0.0814	CcSEcCtD
Bimatoprost—Eye swelling—Cyclosporine—focal segmental glomerulosclerosis	0.0455	0.0814	CcSEcCtD
Bimatoprost—Hypertrichosis—Cyclosporine—focal segmental glomerulosclerosis	0.039	0.0698	CcSEcCtD
Bimatoprost—Conjunctival hyperaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0337	0.0603	CcSEcCtD
Bimatoprost—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.0268	0.0479	CcSEcCtD
Bimatoprost—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.0255	0.0457	CcSEcCtD
Bimatoprost—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0252	0.0451	CcSEcCtD
Bimatoprost—PTGER3—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.0241	0.058	CbGpPWpGaD
Bimatoprost—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.0213	0.0382	CcSEcCtD
Bimatoprost—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.0183	0.0328	CcSEcCtD
Bimatoprost—PTGFR—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.018	0.0433	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.0177	0.0424	CbGpPWpGaD
Bimatoprost—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.0161	0.0288	CcSEcCtD
Bimatoprost—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.0156	0.0279	CcSEcCtD
Bimatoprost—AKR1C3—Retinoid metabolism and transport—LPL—focal segmental glomerulosclerosis	0.0129	0.0309	CbGpPWpGaD
Bimatoprost—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0213	CcSEcCtD
Bimatoprost—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0203	CcSEcCtD
Bimatoprost—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0111	0.0198	CcSEcCtD
Bimatoprost—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00986	0.0177	CcSEcCtD
Bimatoprost—AKR1C3—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.00938	0.0225	CbGpPWpGaD
Bimatoprost—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00894	0.016	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00864	0.0155	CcSEcCtD
Bimatoprost—PTGER1—kidney—focal segmental glomerulosclerosis	0.00829	0.325	CbGeAlD
Bimatoprost—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00826	0.0148	CcSEcCtD
Bimatoprost—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00778	0.0139	CcSEcCtD
Bimatoprost—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00746	0.0134	CcSEcCtD
Bimatoprost—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00738	0.0132	CcSEcCtD
Bimatoprost—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00731	0.0131	CcSEcCtD
Bimatoprost—PTGER3—kidney—focal segmental glomerulosclerosis	0.00727	0.285	CbGeAlD
Bimatoprost—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00717	0.0128	CcSEcCtD
Bimatoprost—PTGER3—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.00713	0.0171	CbGpPWpGaD
Bimatoprost—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00675	0.0121	CcSEcCtD
Bimatoprost—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00671	0.012	CcSEcCtD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00662	0.0159	CbGpPWpGaD
Bimatoprost—AKR1C3—Diseases associated with visual transduction—LPL—focal segmental glomerulosclerosis	0.00657	0.0158	CbGpPWpGaD
Bimatoprost—PTGFR—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.00644	0.0155	CbGpPWpGaD
Bimatoprost—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00636	0.0114	CcSEcCtD
Bimatoprost—PTGER1—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.0063	0.0151	CbGpPWpGaD
Bimatoprost—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00629	0.0113	CcSEcCtD
Bimatoprost—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.0061	0.0109	CcSEcCtD
Bimatoprost—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00582	0.0104	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.00576	0.0138	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00567	0.0136	CbGpPWpGaD
Bimatoprost—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00565	0.0101	CcSEcCtD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.00564	0.0135	CbGpPWpGaD
Bimatoprost—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00559	0.01	CcSEcCtD
Bimatoprost—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00551	0.00988	CcSEcCtD
Bimatoprost—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.0055	0.00984	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00548	0.00981	CcSEcCtD
Bimatoprost—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00539	0.00966	CcSEcCtD
Bimatoprost—PTGFR—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.00538	0.0129	CbGpPWpGaD
Bimatoprost—AKR1C3—nephron tubule—focal segmental glomerulosclerosis	0.00537	0.21	CbGeAlD
Bimatoprost—PTGER1—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.00527	0.0127	CbGpPWpGaD
Bimatoprost—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00525	0.00941	CcSEcCtD
Bimatoprost—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00518	0.00929	CcSEcCtD
Bimatoprost—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00513	0.0092	CcSEcCtD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00509	0.0122	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00495	0.0119	CbGpPWpGaD
Bimatoprost—PTGFR—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.00492	0.0118	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00484	0.0116	CbGpPWpGaD
Bimatoprost—PTGER1—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.00482	0.0116	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.00481	0.0116	CbGpPWpGaD
Bimatoprost—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00478	0.00856	CcSEcCtD
Bimatoprost—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00471	0.00844	CcSEcCtD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.00471	0.0113	CbGpPWpGaD
Bimatoprost—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.0047	0.00842	CcSEcCtD
Bimatoprost—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00465	0.00834	CcSEcCtD
Bimatoprost—AKR1C3—cortex of kidney—focal segmental glomerulosclerosis	0.0046	0.18	CbGeAlD
Bimatoprost—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00456	0.00817	CcSEcCtD
Bimatoprost—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00452	0.0081	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.0044	0.0106	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00436	0.0105	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00432	0.0104	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00431	0.0104	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00424	0.0102	CbGpPWpGaD
Bimatoprost—PTGFR—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00417	0.01	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00415	0.00997	CbGpPWpGaD
Bimatoprost—PTGER1—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00409	0.00982	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00386	0.00927	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00381	0.00914	CbGpPWpGaD
Bimatoprost—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00379	0.00679	CcSEcCtD
Bimatoprost—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00374	0.0067	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00373	0.00897	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00373	0.00895	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.0037	0.00888	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00365	0.00878	CbGpPWpGaD
Bimatoprost—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.0035	0.00626	CcSEcCtD
Bimatoprost—PTGFR—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00346	0.00832	CbGpPWpGaD
Bimatoprost—PTGER1—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00339	0.00815	CbGpPWpGaD
Bimatoprost—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.00597	CcSEcCtD
Bimatoprost—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.00596	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00332	0.00798	CbGpPWpGaD
Bimatoprost—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00331	0.00593	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00326	0.00783	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00323	0.00776	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00319	0.00767	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00316	0.00759	CbGpPWpGaD
Bimatoprost—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00562	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.0031	0.00744	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00307	0.00737	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00303	0.00729	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00281	0.00676	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00276	0.00664	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00271	0.0065	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00257	0.00618	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00248	0.00597	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00245	0.0059	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00244	0.00586	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00243	0.00584	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00234	0.00561	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00231	0.00554	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00229	0.00551	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00227	0.00544	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00225	0.0054	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00223	0.00535	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00222	0.00532	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00212	0.00509	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.0021	0.00506	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00206	0.00495	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00205	0.00493	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00188	0.00451	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00186	0.00448	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00184	0.00441	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00182	0.00438	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.0018	0.00432	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00179	0.0043	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00179	0.00429	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00175	0.0042	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00172	0.00414	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00171	0.00411	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.0017	0.00409	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00169	0.00405	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00167	0.004	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00166	0.00398	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00163	0.00392	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00163	0.00391	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00162	0.0039	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00159	0.00382	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00158	0.00381	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00157	0.00377	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00155	0.00373	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00153	0.00369	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0015	0.00361	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.0015	0.00359	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00144	0.00347	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.0014	0.00337	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00139	0.00335	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00137	0.0033	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00136	0.00328	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00134	0.00323	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00134	0.00322	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00132	0.00317	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00132	0.00316	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00131	0.00315	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00131	0.00315	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00127	0.00306	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00126	0.00304	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00125	0.003	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.0012	0.00288	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00119	0.00286	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00116	0.0028	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00115	0.00275	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.0011	0.00264	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00108	0.0026	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00106	0.00254	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.00103	0.00248	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00101	0.00242	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00101	0.00242	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000987	0.00237	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000985	0.00237	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000979	0.00235	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000966	0.00232	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000964	0.00232	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000958	0.0023	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00093	0.00223	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000929	0.00223	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000924	0.00222	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000897	0.00215	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000878	0.00211	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000853	0.00205	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—LPL—focal segmental glomerulosclerosis	0.000835	0.00201	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000828	0.00199	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000823	0.00198	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000806	0.00194	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000784	0.00188	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000777	0.00187	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000753	0.00181	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000737	0.00177	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000711	0.00171	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000708	0.0017	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—LPL—focal segmental glomerulosclerosis	0.000699	0.00168	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000655	0.00157	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOS2—focal segmental glomerulosclerosis	0.000652	0.00157	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000638	0.00153	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000625	0.0015	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000619	0.00149	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000606	0.00146	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000603	0.00145	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AGT—focal segmental glomerulosclerosis	0.000598	0.00144	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000586	0.00141	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000585	0.0014	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000574	0.00138	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000554	0.00133	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SERPINE1—focal segmental glomerulosclerosis	0.000549	0.00132	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000545	0.00131	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00053	0.00127	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000518	0.00125	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.0005	0.0012	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000489	0.00118	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000479	0.00115	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000462	0.00111	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ALB—focal segmental glomerulosclerosis	0.000459	0.0011	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000417	0.001	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000407	0.000978	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000399	0.000958	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000385	0.000924	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TGFB1—focal segmental glomerulosclerosis	0.000347	0.000833	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000344	0.000826	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000312	0.000749	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000305	0.000734	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000295	0.000708	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000257	0.000618	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000252	0.000605	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000243	0.000583	CbGpPWpGaD
